由前沿细胞设计技术塑造的医疗未来
细胞设计医学研究所(RICeD)旨在成为国际化的研发中心,通过创新的细胞设计技术——山口大学的核心优势,不断培育出下一代细胞和基因疗法的创新成果。
RICeD还致力于推动基于创新技术的前沿免疫疗法和基因组医学的实际应用,开发用于癌症和遗传病等疑难疾病的治疗方法,并在伴侣动物中应用和验证这些创新疗法。
通过在人类和伴侣动物之间建立知识互通的积极循环,RICeD将努力通过技术的社会应用形成药物发现生态系统,推动地方社区发展,通过产业创造培养人才,并延长人类和伴侣动物的健康寿命。
- ALL
- News
- Thesis
- Recruiting
News
2026.06.02
Research and Development of Next-Generation CAR-T Cell Therapy for Malignant Brain Tumor (Glioblastoma) Selected by AMED for Physician-Initiated Clinical Trials: An Academic-Industrial Collaboration Project by Kyushu University, Yamaguchi University, and Noile-Immune Biotech
News
2026.05.29
*Announcement*Article Published in The Nikkei
News
2026.05.14
*Announcement* Lecturer Naomi Tominaga Selected for the JST “FOREST” Program
News
2026.04.28
*Announcement* Symposium “Fusion of Cell Design and Regulatory Science” to be held on July 25 (Sat)
News
2026.04.24
*Announcement* External Lecturer Seminar on Friday, June 26
News
2026.04.20
*Report*The 2nd RICeD Colloquium Held
News
2026.04.16
*Announcement* We will exhibit at “Wonderful” on April 19 (Sun)
News
2026.04.01
*Report*International Seminar Held on Mar 31
Thesis
2026.05.25
Extracellular vesicle microRNAs from human bone marrow MSCs suppress fibrogenesis of hepatic stellate cells by downregulation of RhoA signaling
Thesis
2026.05.18
Incidence and risk factors of acute blood pressure drops during circular-array pulsed-field ablation for pulmonary vein isolation
Thesis
2026.05.15
Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline
Thesis
2026.05.14
[Review] Elucidating the Mechanism of Inflammatory Amplification in Kawasaki Disease: The Role of the IL-33/ST2 Signaling Pathway
Thesis
2026.05.08
miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2
Thesis
2026.04.30
High Flexibility of the Feline Thorax: New Insights into the “Cat-Righting Reflex”
Thesis
2026.04.20
Efficient gene disruption with CRISPR–Cas3 in human T cells
Thesis
2026.03.31
Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels
The article could not be found.
News
2026.06.02
Research and Development of Next-Generation CAR-T Cell Therapy for Malignant Brain Tumor (Glioblastoma) Selected by AMED for Physician-Initiated Clinical Trials: An Academic-Industrial Collaboration Project by Kyushu University, Yamaguchi University, and Noile-Immune Biotech
News
2026.05.29
*Announcement*Article Published in The Nikkei
Thesis
2026.05.25
Extracellular vesicle microRNAs from human bone marrow MSCs suppress fibrogenesis of hepatic stellate cells by downregulation of RhoA signaling
Thesis
2026.05.18
Incidence and risk factors of acute blood pressure drops during circular-array pulsed-field ablation for pulmonary vein isolation
Thesis
2026.05.15
Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline
Thesis
2026.05.14
[Review] Elucidating the Mechanism of Inflammatory Amplification in Kawasaki Disease: The Role of the IL-33/ST2 Signaling Pathway
News
2026.05.14
*Announcement* Lecturer Naomi Tominaga Selected for the JST “FOREST” Program
Thesis
2026.05.08
miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2
RICeD捐款请求
我们正在推进尖端癌症免疫疗法的开发,以治愈更多患者。
我们还致力于将全球首创的基因编辑技术应用于伴侣动物的遗传病治疗,并将研究成果进一步应用于人类医学,以延长人类和伴侣动物的健康寿命。为实现这些目标,并持续推动研究成果的社会应用,我们真诚地请求您的支持。
ー Follow us! ー
